Matthew R. Patterson, Chief Executive Officer at Audentes Therapeutics, Inc. (BOLD), sold 39,000 shares at $34.02 ($1.3M) on 2019-08-12, disclosed to the SEC on 2019-08-14.
Open-market sale of $1.3M BOLD by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.02 | 19,000 | $646K | 48.7% |
| 2 | $34.02 | 19,000 | $646K | 48.7% |
| 3 | $34.53 | 1,000 | $35K | 2.6% |
| Total | $34.03 avg | 39,000 | $1.3M | 100% |
| Filing → |
| BOLD | SELL | 2018-10-02 | $1.6M | — | Filing → |
| BOLD | SELL | 2018-09-20 | $518K | — | Filing → |
| BOLD | SELL | 2018-07-05 | $5.6M | — | Filing → |